Get the Stockscreener App
1.01
0.00%
0.00
Oncolytics Biotech Inc stock is traded at $1.01, with a volume of 472.28K.
It is up +0.00% in the last 24 hours and down -18.55% over the past month.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
See More
Previous Close:
$1.01
Open:
$1
24h Volume:
472.28K
Relative Volume:
0.40
Market Cap:
$98.38M
Revenue:
-
Net Income/Loss:
$-20.31M
P/E Ratio:
-3.8185
EPS:
-0.2645
Net Cash Flow:
$-21.07M
1W Performance:
-6.48%
1M Performance:
-18.55%
6M Performance:
+39.20%
1Y Performance:
+6.32%
1-Day Range:
$0.99
$1.05
1-Week Range:
$0.96
$1.09
52-Week Range:
$0.3258
$1.53
Oncolytics Biotech Inc Stock (ONCY) Company Profile
Compare ONCY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.01 | 101.36M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Initiated | Lake Street | Buy |
| Oct-06-22 | Initiated | Maxim Group | Buy |
| Feb-17-21 | Initiated | H.C. Wainwright | Buy |
Oncolytics Biotech Inc Stock (ONCY) Latest News
Oncolytics names Jared Kelly as CEO - MSN
Will Oncolytics Biotech Inc. benefit from geopolitical trendsJuly 2025 Earnings & Safe Entry Momentum Stock Tips - classian.co.kr
Does Oncolytics Biotech Inc. qualify in momentum factor screeningWeekly Profit Recap & Real-Time Stock Price Movement Reports - Newser
How to build a custom watchlist for Oncolytics Biotech Inc.July 2025 Retail & AI Forecasted Entry and Exit Points - Newser
Trend analysis for Oncolytics Biotech Inc. this weekMarket Growth Report & Safe Swing Trade Setups - Newser
Applying big data sentiment scoring on Oncolytics Biotech Inc.July 2025 Trade Ideas & Daily Chart Pattern Signal Reports - Newser
Is Oncolytics Biotech Inc. building a consolidation base2025 Institutional Moves & Real-Time Stock Movement Alerts - Newser
Will Oncolytics Biotech Inc. stock recover after recent dropTreasury Yields & Technical Analysis for Trade Confirmation - Newser
Published on: 2025-08-19 22:03:12 - Newser
Long term hold vs stop loss in Oncolytics Biotech Inc.Market Growth Report & Fast Gain Stock Tips - Newser
Oncolytics Biotech Inc. recovery potential after sell off2025 Growth vs Value & Daily Stock Trend Reports - Newser
Oncolytics Biotech Inc. stock retracement – recovery analysis2025 Institutional Moves & Fast Gaining Stock Strategy Reports - Newser
Real time breakdown of Oncolytics Biotech Inc. stock performanceMarket Risk Summary & Daily Market Momentum Tracking - Newser
Oncolytics Biotech Inc. Flashes Rebound Signal in Oversold ConditionSwing Trade & Weekly Breakout Stock Alerts - metrotimes.co.kr
Fibonacci Retracement Aligns with Support in Oncolytics Biotech Inc.2025 Trading Volume Trends & Real-Time Chart Pattern Alerts - kangso.co.kr
Is Oncolytics Biotech Inc. currently under institutional pressureQuarterly Growth Report & Weekly Top Gainers Alerts - thegnnews.com
Key metrics from Oncolytics Biotech Inc.’s quarterly dataMarket Performance Summary & Stepwise Entry/Exit Trade Alerts - Newser
Does Oncolytics Biotech Inc. show high probability of reboundJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - Newser
MACD Cross Could Confirm Trend in Oncolytics Biotech Inc.Quarterly Profit Review & Daily Stock Trend Watchlist - beatles.ru
Oncolytics Biotech (NASDAQ:ONCY) Raised to Hold at Wall Street Zen - Defense World
Lake Street Capital Begins Coverage on Oncolytics Biotech (NASDAQ:ONCY) - Defense World
Lake Street Capital Upgrades Oncolytics Biotech (TSE:ONC) to Strong-Buy - Defense World
Cancer Treatment Stocks Surge as $866B Market Attracts Private Investment - Cantech Letter
Oncolytics Biotech Inc. Price Targets Raised After ReboundJuly 2025 PreEarnings & Daily Momentum Trading Reports - newsyoung.net
Oncolytics Biotech Enters Registration-Enabling Trial for Flagship Asset Pelareorep in First-Line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - AInvest
Biotech Stocks Rally as Oncology Market Targets $866B by 2034 - PR Newswire UK
ONCYBiotech Stocks Rally as Oncology Market Targets $866B by 2034 - mx.advfn.com
FDA Fast-Track Cancer Treatments Drive $900B Market Growth Forecast - Baystreet.ca
Oncolytics Biotech Announces AGM Voting Results - TipRanks
Lake Street Initiates Oncolytics Biotech(ONCY.US) With Buy Rating, Announces Target Price $7 - 富途牛牛
Oncolytics Biotech shares rise 12.79% premarket after announcing positive voting results from its Annual General Meeting. - AInvest
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders - easternprogress.com
Live Chart Scan Detects Wedge Pattern in Oncolytics Biotech Inc.Buy Low Sell High Stock Watch Strategy in Focus - 선데이타임즈
Can Oncolytics Biotech Inc. reach all time highs this yearDaily High ROI Stock Ideas - newsyoung.net
Oncolytics Biotech’s Transformative Year: Advancements in mPDAC Treatment with Pelareorep - TipRanks
Oncolytics Biotech’s Strategic Advances and Regulatory Prospects Bolster Buy Rating - TipRanks
Stocks in play: Oncolytics Biotech Inc - The Globe and Mail
Oncolytics Biotech Inc - Baystreet.ca
Stocks In Play: Oncolytics Biotech Inc - Barchart.com
Oncolytics Biotech Announces Voting Results from the Annual General Meeting of Shareholders - MarketScreener
Is Oncolytics Biotech Inc. a turnaround storyExtreme Return Watchlist - thegnnews.com
Oncolytics Biotech announces voting results from annual meeting By Investing.com - Investing.com Canada
Oncolytics Biotech announces voting results from annual meeting - Investing.com
RBC Capital Keeps Buy Rating on Oncolytics Biotech with $3.50 Price Target - AInvest
Oncolytics Biotech(R) Announces Voluntary Delisting from the Toronto Stock Exchange - MarketScreener
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Oncolytics Biotech Advances Pelareorep with Strategic Moves - MSN
Oncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock Exchange - Eastern Progress
Oncolytics Biotech: A High-Conviction Play in the Next-Gen Immunotherapy Space - AInvest
Oncolytics Biotech Inc Stock (ONCY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):